Filter
4527
Filtered Results: 4527
Text search:
preganancy
Featured
Recommendations
378
New Publications
1477
Language
Document type
No document type
2994
Guidelines
539
Studies & Reports
488
Manuals
144
Fact sheets
107
Strategic & Response Plan
90
Training Material
69
Infographics
32
Situation Updates
22
Brochures
19
Resource Platforms
11
Videos
7
Online Courses
3
App
2
Countries / Regions
India
267
Kenya
163
Ethiopia
133
Nepal
131
Global
125
South Africa
117
Sierra Leone
107
Uganda
107
Nigeria
101
Zambia
99
Tanzania
96
Malawi
92
Rwanda
89
Liberia
87
Bangladesh
85
Myanmar / Burma
61
Ghana
57
Philippines
53
Latin America and the Carribbean
53
Namibia
48
Western and Central Europe
48
Lesotho
43
Zimbabwe
42
Cambodia
37
Indonesia
37
Senegal
34
Africa
34
Syria
32
Ukraine
31
Congo, Democratic Republic of
29
Haiti
29
Botswana
29
Germany
28
Brazil
28
Russia
26
South–East Asia Region
23
South Sudan
21
Mozambique
21
Burkina Faso
20
Eswatini/ Swaziland
20
Asia
17
Eastern Europe
17
Guinea
16
Venezuela
16
Cameroon
14
Afghanistan
12
Colombia
12
Pakistan
11
East and Southern Africa
11
Benin
10
Yemen
10
Middle East and North Africa
10
Eastern Europe and Central Asia
9
USA
7
Madagascar
7
West and Central Africa
7
Paraguay
7
Somalia
6
Lebanon
6
Thailand
6
Western Pacific Region
6
Mali
5
Argentina
5
Albania
5
North America
5
Côte d’Ivoire / Ivory Coast
4
Turkey
4
Sudan
4
Peru
4
Bolivia
4
Sri Lanka
4
Southern Africa
4
Laos
4
Tajikistan
4
Georgia
4
Vietnam
4
Togo
3
Jordan
3
Papua New Guinea
3
Burundi
3
Iraq
2
Central African Republic
2
North Macedonia
2
Honduras
2
Ecuador
2
Guatemala
2
Mexico
2
Bhutan
2
Palestine
2
Moldova
2
Egypt
1
Gambia
1
Ireland
1
Dominican Republic
1
Switzerland
1
El Salvador
1
Greece
1
Libya
1
Angola
1
Chile
1
Other region
1
Fiji
1
Solomon Islands
1
Armenia
1
Mongolia
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Lithuania
1
Kyrgyzstan
1
Jamaica
1
France
1
United Kingdom
1
Spain
1
Belarus
1
Latvia
1
United Arab Emirates
1
Authors & Publishers
Publication Years
Category
Countries
2141
Women & Child Health
434
Clinical Guidelines
428
Public Health
176
Capacity Building
123
Key Resources
81
Pharmacy & Technologies
19
Annual Report MEDBOX
1
Toolboxes
HIV
454
COVID-19
272
Mental Health
236
Zika
122
TB
118
Caregiver
118
Refugee
114
Disability
100
Ebola
78
Conflict
76
Rapid Response
73
NCDs
71
Pharmacy
62
NTDs
61
Planetary Health
56
Global Health Education
46
AMR
28
Natural Hazards
23
Health Financing Toolbox
21
Specific Hazards
11
Cholera
10
Polio
7
Social Ethics
7
South Sudan
1
Typhoon
1
Health Financing
1
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
• Leptospirosis is a disease that is caused by
spirochete bacteria in the genus Leptospira.
There are 10 pathogenic species, and more
than 250 pathogenic serovars.
• While leptospirosis occurs worldwide, it is
more common in tropical or sub-tropical
climates.
The purpose of this guide is to provide practical advice for health staff undertaking infectious disease preparedness and response activities to ensure that access to safe abortion care (SAC) is maintained when an infectious disease outbreak occurs. It is an operational guide which can serve to supp...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.
The updates are based on evidence emerging from the: Ongoing monitoring of the disease. Protection that the population already developed against COVID-19 through previous infection or vaccination. Epidemiological situation, availability of diagnostic tests and access to therapeutic options.
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
This publication articulates the WHO Botswana Country Office’s focus and investment needs for the biennium 2022–2023, building on achievements, networks, and partnerships fostered in 2020-2021.
As the leading health authority within the United Nations system in Botswana, the WHO Country Offi...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
In October 2022, President Biden signed the Global Malnutrition Prevention and Treatment Act (GMPTA) into law, which directs USAID to prevent and treat malnutrition globally. The GMPTA further codifies USAID’s leadership on nutrition, with a focus on evidence-based interventions across health syst...
Healthcare workers throughout the country should be on high alert for suspected cholera cases, regardless of travel history
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
The International Rescue Committee (IRC) is a leading humanitarian agency dedicated to helping people whose lives have been shattered by conflict and disaster to survive, recover, and gain control of their future. Health comprises nearly half of IRC’s program portfolio globally and encompasses thr...
The document provides Information on alcohol use (risk factors, evaluation alcohol use etc.) in a descriptive way.
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
